Login / Signup

Retinopathy Outcomes With Empagliflozin Versus Placebo in the EMPA-REG OUTCOME Trial.

Catherine M ViscoliChristoph WannerUwe HehnkeIsabella ZwienerStefan KaspersDouglas ClarkJyothis T GeorgeBernard Zinman
Published in: Diabetes care (2019)
Keyphrases
  • phase iii
  • clinical trial
  • study protocol
  • phase ii
  • open label
  • double blind
  • randomized controlled trial
  • type diabetes